Cocrystal Pharma Stock Price

-0.06 (-4.08%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cocrystal Pharma Inc COCP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -4.08% 1.41 08:39:19
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
1.40 1.41 0.01 - -
Trades Volume Avg Volume 52 Week Range
2,105 1,013,595 25,797,096 0.76 - 4.10
Last Trade Time Type Quantity Stock Price Currency
08:39:19 formt 350 $ 1.41 USD

Cocrystal Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 100.77M 71.47M 55.45M $ 2.01M $ - -0.18 -6.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 62.00%

more financials information »

Cocrystal Pharma News

Date Time Source News Article
5/05/202117:03Edgar (US Regulatory)Current Report Filing (8-k)
5/05/202116:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/05/202107:53Edgar (US Regulatory)Current Report Filing (8-k)
5/05/202100:32Seeking AlphaCocrystal Pharma launches $40M stock offering
5/04/202118:41GlobeNewswire Inc.Cocrystal Pharma Announces $40 Million Bought Deal Offering..
5/03/202108:58Seeking AlphaCocrystal Pharma updates on COVID-19 antiviral development..
5/03/202108:00GlobeNewswire Inc.Cocrystal Pharma Provides Update on its COVID-19 Antiviral..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical COCP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.273.461.1752.03124,319,8440.1411.02%
1 Month1.503.461.112.0235,970,061-0.09-6.0%
3 Months2.123.461.112.0013,769,329-0.71-33.49%
6 Months0.843.460.761.949,068,4070.5767.86%
1 Year0.944.100.761.845,912,7250.4750.0%
3 Years1.835.500.38611.742,541,754-0.42-22.95%
5 Years4.366.450.38611.752,421,036-2.95-67.66%

Cocrystal Pharma Description

Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.
Your Recent History
Cocrystal ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 12:54:34